A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.

MLA

Paweena Susantitaphong, et al. “A Double-Blind, Randomized, Placebo-Controlled Trial of Combined Calcitriol and Ergocalciferol versus Ergocalciferol Alone in Chronic Kidney Disease with Proteinuria.” BMC Nephrology, vol. 18, Jan. 2017, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s12882-017-0436-6.

APA

Paweena Susantitaphong, Siriwan Nakwan, Sadudee Peerapornratana, Khajohn Tiranathanagul, Pisut Katavetin, Nattachai Srisawat, Kearkiat Praditpornsilpa, Somchai Eiam-Ong, Susantitaphong, P., Nakwan, S., Peerapornratana, S., Tiranathanagul, K., Katavetin, P., Srisawat, N., Praditpornsilpa, K., & Eiam-Ong, S. (2017). A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria. BMC Nephrology, 18, 1–8. https://doi.org/10.1186/s12882-017-0436-6

Chicago

Paweena Susantitaphong, Siriwan Nakwan, Sadudee Peerapornratana, Khajohn Tiranathanagul, Pisut Katavetin, Nattachai Srisawat, Kearkiat Praditpornsilpa, et al. 2017. “A Double-Blind, Randomized, Placebo-Controlled Trial of Combined Calcitriol and Ergocalciferol versus Ergocalciferol Alone in Chronic Kidney Disease with Proteinuria.” BMC Nephrology 18 (January): 1–8. doi:10.1186/s12882-017-0436-6.